GeneMachines Licenses Microarray Printing Technology from Incyte | GenomeWeb

NEW YORK, July 23 – GeneMachines has licensed two patents covering microarray fabrication technology from Incyte Genomics, the company said Monday.

The license will allow GeneMachines, based in San Carlos, Calif., to sell its microarray printing machines, the OmniGrid and OmniGrid Accent, with label licenses for research use. In a statement, the company made no mention of any changes to their microarraying products, which have been available to customers for several years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.